The Future of Cardio-Oncology Wearables with Ryan Neely

Cancer treatment is already difficult enough without adding more hospital visits, more testing, and more delays. Yet many cancer therapies carry a significant risk of damaging the heart, forcing patients to undergo regular cardiac screening throughout their treatment journey. What if clinicians could monitor cardiac function with a simple wearable patch instead?

In this episode of the Med Device Cyber Podcast, Christian Espinosa sits down with Ryan Neely, co-founder and CEO of Skribe Medical. Ryan shares his journey from neuroscience research and implantable neuroprosthetics to building a company focused on improving cardiac monitoring for cancer patients.

The discussion explores the growing field of cardio-oncology and the challenges patients face when cancer treatment depends on frequent cardiac assessments. Ryan explains how Skribe Medical's wearable monitoring platform aims to reduce treatment delays while improving patient convenience through a battery-free, AI-powered patch designed to measure cardiac function.

The conversation also takes a deep dive into cybersecurity considerations for connected medical devices. Ryan and Christian discuss common misconceptions about cybersecurity risk, why hospital networks often present greater challenges than home environments, and how device manufacturers should think about security as products evolve from standalone systems to connected healthcare technologies.

Finally, the episode explores commercialization, reimbursement models, FDA engagement, and the reality that regulatory clearance is often just one milestone in a much longer journey toward successful adoption.

Whether you're a MedTech founder, healthcare innovator, cybersecurity professional, or clinician, this episode offers valuable insights into the intersection of patient care, connected devices, and healthcare innovation.